51. 全身性強皮症 Scleroderma Clinical trials / Disease details

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03844061 (ClinicalTrials.gov)	July 29, 2019	31/1/2019	Belimumaband Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis ...	A Randomized, Double-Blind, Placebo-Controlled Study of Belimumaband Rituximab Combination Therapy f ...	Systemic Sclerosis	Drug: Belimumab;Drug: Rituximab;Other: Placebo Subcutaneous Injection;Other: Placebo Infusion;Drug: ...	Hospital for Special Surgery, New York	GlaxoSmithKline	Recruiting	18 Years	80 Years	All	30	Phase 2	United States
2	NCT01670565 (ClinicalTrials.gov)	August 2012	15/8/2012	Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis	Belimumabfor the Treatment of Diffuse Cutaneous Systemic Sclerosis: A Phase 2a, Single-centered, Ran ...	Systemic Sclerosis	Drug: Belimumab;Drug: Mycophenolate Mofetil;Other: Placebo Infusion	Hospital for Special Surgery, New York	Human Genome Sciences Inc.	Completed	18 Years	N/A	All	20	Phase 2	United States

First Previous1Next Last